The SaaSpocalypse isn’t killing software. It’s exposing where software value really lives31 July 2026
The Startup Behind The Pill For Sleep Apnea Raises $192 Million In IPOBy Press Room31 July 2026 Even before it gets approval for its sleep apnea pill, Apnimed is testing investor appetite.The Cambridge, Mass.-based biotech priced its…
First Pill For Obstructive Sleep Apnea Shows Promise In Phase 3 StudyBy Press Room30 June 2025 You could say that it’s difficult to mask the challenges that people with obstructive sleep apnea face every day. But…